Functioning as antimicrobial peptides, Reg3b and Reg3g express in response to the conditions of STAT3 hyperactivation as well as the upregulation of inflammatory cytokines such as IL‐18 and IL‐22 in intestinal epithelial cells during IBD. Here, IL22 is linked to inflammatory bowel disease.